Know Labs Inc
OTC:KNWN
Intrinsic Value
Know Labs, Inc. engages in the development, marketing, and sale of a photonics technology. [ Read More ]
The intrinsic value of one KNWN stock under the Base Case scenario is 0.24 USD. Compared to the current market price of 1.52 USD, Know Labs Inc is Overvalued by 84%.
Valuation Backtest
Know Labs Inc
Run backtest to discover the historical profit from buying and selling KNWN stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Know Labs Inc
Know Labs Inc
Earnings Waterfall
Know Labs Inc
Revenue
|
4.4m
USD
|
Operating Expenses
|
-16.9m
USD
|
Operating Income
|
-12.6m
USD
|
Other Expenses
|
-7.5m
USD
|
Net Income
|
-20.1m
USD
|
Free Cash Flow Analysis
Know Labs Inc
What is Free Cash Flow?
KNWN Profitability Score
Profitability Due Diligence
Know Labs Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.
Score
Know Labs Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.
KNWN Solvency Score
Solvency Due Diligence
Know Labs Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Score
Know Labs Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
KNWN Price Targets Summary
Know Labs Inc
Ownership
KNWN Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
KNWN Price
Know Labs Inc
Average Annual Return | 37.76% |
Standard Deviation of Annual Returns | 52.11% |
Max Drawdown | -70% |
Market Capitalization | 66.5m USD |
Shares Outstanding | 43 737 772 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Know Labs, Inc. engages in the development, marketing, and sale of a photonics technology. The company is headquartered in Seattle, Washington and currently employs 12 full-time employees. The company went IPO on 2006-04-12. The firm offers technology that uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The firm offers a technology called Bio-RFID, which identifies and provides the user with real-time information on their blood glucose levels. Bio-RFID can be integrated into a variety of wearable, mobile or bench-top form factors. Bio-RFID uses radio waves to identify and measure what is going on inside the body. The firm offers UBAND, which is a wearable non-invasive glucose monitor that measures blood glucose levels without fingerpricks or needles. The company helps people with diabetes and pre-diabetes manage their conditions. UBAND’s Bio-RFID sensor detects molecular signatures in other substances such as oxygen, alcohol, and metabolized drugs. Its user can subscribe to multiple monthly services for medical reasons and others lifestyle.
Contact
IPO
Employees
Officers
The intrinsic value of one KNWN stock under the Base Case scenario is 0.24 USD.
Compared to the current market price of 1.52 USD, Know Labs Inc is Overvalued by 84%.